2025-520946-31-00招募中1 期
Phase I clinical trial evaluating TG4070 in patients with non-small cell lung cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Transgene
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Transgene medical affairs
Scientific
Transgene
研究点 (1)
Loading locations...
相似试验
招募中
1 期
Phase I clinical trial of TG4050 combined with nivolumab in patients with Non-Small Cell Lung Cancer.Non-Small Cell Lung Cancer2024-514001-65-00Transgene20
已完成
1 期
Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C VirusHepatitis C, ChronicNCT00529321Transgene42
已完成
1 期
Phase I Clinical Trial of EA4017: Clinical Pharmacology Study in Healthy Adult Male SubjectsHealthy adult subjectsJPRN-jRCT2080224789EA Pharma Co., Ltd.160
已完成
1 期
Phase I Clinical Trial of EA4017: Clinical Pharmacology Study in Healthy Adult Male SubjectsjRCT2080224789EA Pharma Co., Ltd.160
已完成
1 期
GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Blastic Phase Chronic Myelogenous Leukemiade Novo Myelodysplastic SyndromesPreviously Treated Myelodysplastic SyndromesRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid LeukemiaRelapsing Chronic Myelogenous LeukemiaSecondary Acute Myeloid LeukemiaSecondary Myelodysplastic SyndromesUntreated Adult Acute Lymphoblastic LeukemiaUntreated Adult Acute Myeloid LeukemiaAcute Undifferentiated LeukemiaNCT00459212National Cancer Institute (NCI)24